Evogene's market cap is currently $7.42M. The company's EPS TTM is $-4.446; its P/E ratio is ―; Evogene is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 5.64M	$ 1.68M	$ 930.00K	$ 1.04M	$ 753.00K
Gross Profit	$ 1.40M	$ 766.00K	$ 163.00K	$ 466.00K	$ 419.00K
Operating Income	$ -26.39M	$ -26.94M	$ -30.95M	$ -24.81M	$ -21.17M
EBITDA	$ -23.20M	$ -26.93M	$ -27.80M	$ -23.18M	$ -15.97M
Net Income	$ -23.88M	$ -26.64M	$ -27.79M	$ -23.37M	$ -18.11M
Balance Sheet
Cash & Short-Term Investments	$ 31.06M	$ 35.35M	$ 53.87M	$ 48.23M	$ 46.88M
Total Assets	$ 51.10M	$ 56.13M	$ 76.30M	$ 71.92M	$ 71.36M
Total Debt	$ 11.51M	$ 11.93M	$ 2.67M	$ 2.44M	$ 2.97M
Net Debt	$ -9.27M	$ -17.05M	$ -29.66M	$ -43.79M	$ -31.78M
Total Liabilities	$ 22.42M	$ 21.34M	$ 12.88M	$ 15.03M	$ 11.15M
Stockholders' Equity	$ 12.05M	$ 27.93M	$ 54.03M	$ 46.05M	$ 50.14M
Cash Flow
Free Cash Flow	$ -22.36M	$ -24.85M	$ -25.56M	$ -20.20M	$ -18.26M
Operating Cash Flow	$ -21.58M	$ -23.68M	$ -24.84M	$ -19.51M	$ -17.36M
Investing Cash Flow	$ -4.54M	$ 13.27M	$ -20.44M	$ 9.41M	$ 37.14M
Financing Cash Flow	$ 18.15M	$ 9.34M	$ 30.28M	$ 20.37M	$ 9.00M

Currency in USD

Evogene Earnings and Revenue History

Income Statement >

Evogene Debt to Assets

Balance Sheet >

Evogene Cash Flow

Cash Flow >

Evogene Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing